Age-related macular degeneration, often shortened to macular degeneration, is a common condition that causes vision loss in people over the age of 60. It occurs in two forms, which include wet and dry macular degeneration. Each type is treated differently, with one popular method for both being drug therapy. At Outlook Eyecare, our team offers effective macular degeneration treatment that utilizes medication, helping to slow its progression and allow our patients to see and feel better.
Although there is no cure for macular degeneration, there are several different treatments that can slow its effects. Among these methods, drug therapy is a common route to take, especially when treating wet macular degeneration. At Outlook Eyecare, we work with our patients to determine which of the following drugs will work best with their unique case of macular degeneration:
Most macular degeneration drug therapies are categorized as vascular endothelial growth factor (VEGF) therapies. These forms of treatment are injected directly into the affected eye(s) by one of our trained physicians. Although this sounds uncomfortable, patients usually do not experience extreme distress during this relatively short procedure. Lasting as little as 15 minutes, VEGF drug administration is preceded by anesthetics. After the target eye is numbed, the injection is administered.
VEGF drugs work by preventing new blood vessels from forming behind the retina. When blood vessels do develop, they can leak into your retina, destroying your macular cells and causing macular degeneration. The effects of VEGF drugs typically last for a month or more, meaning patients with macular degeneration usually receive injections every four weeks. In some cases, VEGF drug therapy can shrink the blood vessels in your retina, absorbing fluid and restoring limited function to your eye(s).
If you have macular generation, then drug therapy is one of the most effective treatment options you can pursue. The benefits of this path are clear: you can slow or stop your macular generation and even have the potential to regain some vision in the affected eye(s).
Like any procedure, drug therapies for macular generation carry certain risks. These include eye infection, increased eye pressure, retinal detachment, and vitreous floaters. Although these are rare, the Outlook Eyecare team will answer any questions you may have about the risks of this treatment path.
At Outlook Eyecare, our team of practitioners includes some of the leading optical professionals in the state of New Jersey. With specializations in cataract surgery, glaucoma, and much more, we know what it takes to get macular degeneration treatment right the first time. We also uniquely offer the latest and most advanced eye health services in a boutique-style setting that is centered on the patient, as well as a convenient on-site optical shop that makes getting glasses and contact lenses easy.
With years of experience under our belt, you can trust Outlook Eyecare to treat your macular degeneration with drug therapies or other means that best suits your diagnosis. With locations in Monroe Township and Princeton, our patients can choose to visit whichever is most convenient for them. To schedule an appointment, call our Monroe Township office at 609-409-2777 or our Princeton office at 609-419-1920 today.
2019 Outlook Eyecare © All rights reserved.